Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Clayton

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Advances in Psychosomatic Medicine|April 9, 2008
The impact of physical illness on sexual dysfunctionAnita Clayton, Sujatha Ramamurthy
Sexual Medicine|January 3, 2017
What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire DisorderRobert Pyke, Anita Clayton
Menopause (New York, N.Y.)|August 19, 2008
Recognition of depression among women presenting with menopausal symptomsAnita Clayton, Christine Guico-Pabia
The Journal of Sexual Medicine|April 17, 2007
Proposal for changes in diagnostic criteria for sexual dysfunctionsRobert Segraves, Richard Balon, Anita Clayton
Journal of Affective Disorders|January 25, 2006
Burden of phase-specific sexual dysfunction with SSRIsAnita Clayton, Adrienne Keller, Elizabeth L McGarvey
The Journal of Sexual Medicine|August 14, 2019
Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled TrialPaula Jacobsen, Wei Zhong, George Nomikos, et al.
The Journal of Sexual Medicine|July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorderAnita Clayton, Susan Kornstein, Apurva Prakash, et al.
Journal of Clinical Psychopharmacology|May 1, 2004
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal womenRobert Taylor Segraves, Anita Clayton, Harry Croft, et al.
The Journal of Sexual Medicine|November 29, 2007
Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorderLeonard Derogatis, Anita Clayton, Diane Lewis-D'Agostino, et al.
Menopause (New York, N.Y.)|January 23, 2014
Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorderSusan G Kornstein, Anita Clayton, Weihang Bao, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Advances in Psychosomatic Medicine|April 9, 2008
The impact of physical illness on sexual dysfunctionAnita Clayton, Sujatha Ramamurthy
Sexual Medicine|January 3, 2017
What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire DisorderRobert Pyke, Anita Clayton
Menopause (New York, N.Y.)|August 19, 2008
Recognition of depression among women presenting with menopausal symptomsAnita Clayton, Christine Guico-Pabia
The Journal of Sexual Medicine|April 17, 2007
Proposal for changes in diagnostic criteria for sexual dysfunctionsRobert Segraves, Richard Balon, Anita Clayton
Journal of Affective Disorders|January 25, 2006
Burden of phase-specific sexual dysfunction with SSRIsAnita Clayton, Adrienne Keller, Elizabeth L McGarvey
The Journal of Sexual Medicine|August 14, 2019
Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled TrialPaula Jacobsen, Wei Zhong, George Nomikos, et al.
The Journal of Sexual Medicine|July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorderAnita Clayton, Susan Kornstein, Apurva Prakash, et al.
Journal of Clinical Psychopharmacology|May 1, 2004
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal womenRobert Taylor Segraves, Anita Clayton, Harry Croft, et al.
The Journal of Sexual Medicine|November 29, 2007
Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorderLeonard Derogatis, Anita Clayton, Diane Lewis-D'Agostino, et al.
Menopause (New York, N.Y.)|January 23, 2014
Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorderSusan G Kornstein, Anita Clayton, Weihang Bao, et al.
Pageof 2